MERIT MEDICAL SYSTEMS INC

For the period ended Sep 30, 2026. Filed Oct 29, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 29, 2026

MMSI$88.42+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands)


· · September 30, · · December 31,
ASSETS · · 2026 · · 2025
	(unaudited)
Current assets: · · · ·
Cash and cash equivalents	$503,551	$446,404
Trade receivables — net of allowance for credit losses — 2026 — $10,994 and 2025 — $10,136	221,866	203,710
Other receivables	37,875	17,773
Inventories	391,022	333,705
Prepaid expenses and other current assets	35,188	31,493
Prepaid income taxes	5,030	4,941
Income tax refund receivables	4,283	2,128
Total current assets	1,198,815	1,040,154

Property and equipment:
Land and land improvements	30,332	30,465
Buildings	238,765	200,046
Manufacturing equipment	394,081	365,277
Furniture and fixtures	62,773	60,883
Leasehold improvements	67,099	65,236
Construction-in-progress	40,745	82,939
Total property and equipment	833,795	804,846
Less accumulated depreciation	(396,448)	(376,445)
Property and equipment — net	437,347	428,401

Other assets:
Intangible assets:
Developed technology — net of accumulated amortization — 2026 — $491,025 and 2025 — $452,525	522,618	465,940
Other — net of accumulated amortization — 2026 — $100,924 and 2025 — $96,436	68,586	71,714
Goodwill	537,135	506,837
Deferred income tax assets	7,273	7,049
Right-of-use operating lease assets	84,379	87,600
Other assets	68,753	78,227
Total other assets	1,288,744	1,217,367

Total assets	$2,924,906	$2,685,922


See condensed notes to consolidated financial statements.	(continued)

CONSOLIDATED BALANCE SHEETS

(In thousands)


· · September 30, · · December 31,
LIABILITIES AND STOCKHOLDERS’ EQUITY · · 2026 · · 2025
	(unaudited)
Current liabilities: · · · · ·
Trade payables	$66,286	$60,551
Accrued expenses	174,024	159,486
Short-term operating lease liabilities	10,382	10,876
Income taxes payable	14,391	8,851
Total current liabilities	265,083	239,764

Long-term debt	737,404	734,038
Deferred income tax liabilities	37,216	19,665
Liabilities related to unrecognized tax benefits	2,248	2,248
Deferred compensation payable	19,373	17,542
Deferred credits	1,321	1,398
Long-term operating lease liabilities	74,273	76,658
Other long-term obligations	43,437	10,306
Total liabilities	1,180,355	1,101,619

Commitments and contingencies

Stockholders’ equity:
Preferred stock — 5,000 shares authorized; no shares issued as of September 30, 2026 and December 31, 2025	—	—
Common stock, no par value — 100,000 shares authorized; issued and outstanding as of September 30, 2026 - 59,898 and December 31, 2025 - 59,424	808,930	763,909
Retained earnings	946,139	824,030
Accumulated other comprehensive loss	(10,518)	(3,636)
Total stockholders’ equity	1,744,551	1,584,303

Total liabilities and stockholders’ equity	$2,924,906	$2,685,922


See condensed notes to consolidated financial statements.	(concluded)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.